Delivery Order SPE2DB22D2206-SPE2DB25FJE44
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $39,550.98 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026). The delivery order is scheduled for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,361.72 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate completion date of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,677.48 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract, designated as a firm fixed price delivery order with no set-aside provisions, represents a child award under the company's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $59,466 on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitive award carries a firm fixed price structure and no set-aside designation. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical products and medical supplies for military and veteran healthcare systems....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively bid delivery order valued at $98,786.59 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $187,438.32 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. This firm fixed-price contract, which has no set-aside designation, is scheduled for completion by July 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.99 million...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $180,530.39 on July 30, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is classified as a child order under a larger Indefinite Delivery Contract vehicle and will be performed at the company's Conshohocken facility with an ultimate completion date of July 31, 2025. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $31,726.08 by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed price contract, awarded on August 2, 2025, with an ultimate completion date of August 4, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively bid delivery order valued at $166,629.96 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. This firm fixed-price contract, issued without set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,210.08 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price, competitively awarded contract (no set-aside used) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJE44Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for SCEMBLIX 40 mg tablets in quantities of 60 units. The contract is valued at $13,259.50 under a firm fixed-price arrangement with a completion date of August 21, 2025. This award represents a competitive procurement with no set-aside designation and serves as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026. The delivery order fulfills federal pharmaceutical supply requirements for military and veteran healthcare systems, with performance executed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This transaction reflects the contractor's role as a critical vendor within the DLA Medical Supply Chain, supplying an extensive portfolio of pharmaceuticals across multiple therapeutic domains. The award demonstrates AmerisourceBergen's continued capacity to support federal medical procurement through the comprehensive global pharmaceutical support vehicle, which enables distribution of specialty medications, brand-name and generic drugs, and related medical commodities to support Defense Health Agency and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 7/31/25 |